Receptor, ErbB-2
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Potential Anti-tumor Effects of SSGJ-705 in Patients With Advanced or Metastatic HER2-expressing Solid Tumors (NCT05145179) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2021-12-01 |
| Evaluation of 68-GaNOTA-Anti-HER2 VHH1 Uptake in Brain Metastasis of Cancer Patients (NCT03331601) | Universitair Ziekenhuis Brussel | 2017-10-16 |
Track Receptor, ErbB-2 automatically
Every clearance here is in the API, with alerts when new ones post.